Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Crinetics Pharmaceuticals Inc.

3 clinical trials · 3 recruiting · INDUSTRY

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Crinetics Pharmaceuticals Inc.

RECRUITINGPhase 1 / Phase 2NCT05804669

A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome

A Phase 1b/2a, first-in-disease, open-label, multiple-ascending dose exploratory study to evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamic biomarker...

Sponsor: Crinetics Pharmaceuticals Inc.Enrolling: 181 location
Cushing SyndromeCushing DiseaseEctopic ACTH Syndrome
RECRUITINGPhase 2 / Phase 3NCT07159841

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of atumelnant treatment in pediatric participants with classic...

Sponsor: Crinetics Pharmaceuticals Inc.Enrolling: 15318 locations
Congenital Adrenal HyperplasiaClassic Congenital Adrenal Hyperplasia
RECRUITINGPhase 2NCT06712823

An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894

The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of atumelnant (CRN04894).

Sponsor: Crinetics Pharmaceuticals Inc.Enrolling: 1509 locations
Congenital Adrenal HyperplasiaClassic Congenital Adrenal Hyperplasia